The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

Citizens: Maintaining its "Outperform Market" rating for BioCryst Pharmaceuticals ( BioCryst Pharmaceuticals, Inc.(BCRX.US) ), while raising its price target from $25 to $28.

Wells Fargo: Maintaining MannKind Corporation's ( MannKind Corporation(MNKD.US) ) rating at "Overweight", while raising the price target from $8 to $10.

HC Wainwright & Co.: Maintaining a "buy" rating on MannKind Corporation ( MannKind Corporation(MNKD.US) ), with a price target raised from $8 to $10.

Oppenheimer: Initial rating for Aprea Therapeutics(APRE.US) ) stock at "outperforms the market", with a price target of $5.

Barclays: Maintaining an "overweight" rating on Alphatec Holdings ( Alphatec Holdings, Inc.(ATEC.US) ), while lowering its price target from $27 to $24.

The symbol	Classification	Target price	Current price	Percentage of potential increase/decrease	(Classification) Agency
BioCryst Pharmaceuticals, Inc.(BCRX.US)	to lift	$28.0	$8.9	214.61%	Citizens
MannKind Corporation(MNKD.US)	to lift	$10.0	$3.55	181.69%	Wells Fargo
MannKind Corporation(MNKD.US)	to lift	$10.0	$3.55	181.69%	HC Wainwright & Co.
Kratos Defense & Security Solutions, Inc.(KTOS.US)	to lift	$130.0	$57.0	128.07%	Canaccord Genuity
Alto Ingredients, Inc.(ALTO.US)	to lift	$10.0	$4.54	120.26%	HC Wainwright & Co.
Aprea Therapeutics(APRE.US)	Initial classification	$5.0	$0.8807	467.73%	Oppenheimer
Alphatec Holdings, Inc.(ATEC.US)	cut	$24.0	$7.75	209.68%	Barclays
Alphatec Holdings, Inc.(ATEC.US)	cut	$23.0	$7.75	196.77%	Canaccord Genuity
Holley Inc.(HLLY.US)	cut	$7.0	$2.53	176.68%	Canaccord Genuity
EyePoint, Inc.(EYPT.US)	cut	$37.0	$13.41	175.91%	RBC Capital

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

Barclays: Maintaining Astera Labs' rating Astera Labs(ALAB.US) ) at "Market Weight", while raising the price target from $165 to $200.

Citigroup: Maintaining its rating on AMD ( Advanced Micro Devices, Inc.(AMD.US) ) at "neutral", while raising its price target from $248 to $358.

Wells Fargo: Maintaining an "overweight" rating on AppLovin AppLovin(APP.US) stock, while raising its price target from $560 to $571.

JP Morgan: Maintaining a "neutral" rating on AppLovin AppLovin(APP.US) ) stock, while raising its price target from $500 to $515.

Mizuho: Maintaining its rating on Arm Holdings ( Arm Holdings(ARM.US) ) at "Outperforming the Market", while raising its price target from $255 to $290.

Keybanc: Maintaining an "overweight" rating on ARM Holdings Arm Holdings(ARM.US) , while raising its price target from $170 to $300.

Rosenblatt: Maintaining a "buy" rating on Coherent Corp. ( Coherent Corp.(COHR.US) ), while raising the price target from $375 to $425.

TD Securities: Maintaining a "buy" rating on Coherent Corp. ( Coherent Corp.(COHR.US) ), while raising the price target from $340 to $395.

Citigroup: Maintaining a "buy" rating on Corning ( Corning Inc(GLW.US) ), while raising the price target from $175 to $225.

Oppenheimer: Maintaining Corning's ( Corning Inc(GLW.US) ) rating at "Outperform Market", while raising the price target from $120 to $210.

Wedbush: Maintaining IonQ's ( IonQ, Inc.(IONQ.US) ) rating at "Outperforming the Market," while raising the price target from $60 to $75.

TD Cowen: Maintaining Strategy ( Strategy(MSTR.US) ) rating at "Buy", while raising the price target from $385 to $395.

Canaccord Genuity: Maintaining Strategy's rating ( Strategy(MSTR.US) ) at "Buy", while raising the price target from $185 to $224.

Citigroup: Maintaining a "buy" rating on Vertiv Holdings VERTIV HOLDINGS LLC(VRT.US) ), raising its price target from $353 to $414.

First Coverage

Oppenheimer: Initial rating for Aprea Therapeutics(APRE.US) ) stock at "outperforms the market", with a price target of $5.

Bernstein: Initial rating for CNH Industrial ( CNH Industrial NV(CNH.US) ) at "Market Match", with a target price of $11.

Brookline Capital: Initial rating for Eterna Therapeutics ( Eterna Therapeutics(ERNA.US) ) at "Buy", with a target price of $30.

Northland Capital Markets: Initial rating for Surf Air Mobility ( Surf Air Mobility, Inc.(SRFM.US) ) at "Outperform," with a price target of $5.

reduction

Baird: Maintaining a "neutral" rating on Lululemon ( lululemon athletica inc.(LULU.US) ), while lowering the price target from $190 to $170

Macquarie: Downgraded PayPal Holdings (PYPL) stock rating to "neutral" with a price target cut from $58 to $50.

Barclays: Maintaining the Super Micro Computer (SMCI) rating at "market-weighted", while lowering the price target from $38 to $34.

DA Davidson: Clear Secure (YOU) downgraded its rating to "neutral", lowering its price target from $65 to $60.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.